New Drug Boosts Breast Cancer Survival
HealthDay News reports here at the Washington Post website: Certain breast cancer patients who switch to the aromatase inhibitor drug anastrozole (Arimidex) after two to three years of treatment with tamoxifen live longer and are more likely to remain cancer-free, German researchers report.